Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Medispar from Brussel, company number BE0875667302, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year Medispar recorded a gross margin of € 153,283 and equity of € 471,959. Compared with financial year 2024, the result moved from € -156,191 to € -1.2 million. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 471,959
▲ 103% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.2 million
▼ 641 % more loss than in 2024
Profit after tax over the fiscal year.
€ 40,302
▼ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.1 million.
People and assets in 2025
4.1
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 728,693
▲ 21% vs 2024
€ 177,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,168
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 200,000
▼ 85% vs 2024
Loans from banks and other lenders, long and short.
€ 500,434
▼ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 107,858
▼ 76% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,078,450 | € 2,259,906 | € 846,021 | € 153,283 | ▼ 82% |
| Profit after taxes | € 534,261 | € 1,548,214 | € -156,191 | € -1,157,639 | ▼ € 1 million |
| Equity | € 1,446,478 | € 388,692 | € 232,501 | € 471,959 | ▲ 103% |
| Total debts | € 3,556,078 | € 5,075,109 | € 3,701,804 | € 2,250,982 | ▼ 39% |
| Cash | € 917,132 | € 755,277 | € 106,609 | € 40,302 | ▼ 62% |
| Retained profit | € 1,283,086 | € 225,300 | € 69,109 | € -1,088,529 | ▼ € 1.2 million |
| Dividend | € 900,000 | € 2,606,000 | € 0 | € 0 | |
| Bank debt | € 1,632,068 | € 1,244,180 | € 1,311,160 | € 200,000 | ▼ 85% |
| Balance sheet total | € 5,002,556 | € 5,463,801 | € 3,934,304 | € 2,722,942 | ▼ 31% |
| Employees (FTE) | 2.3 | 3.4 | 4 | 4.1 | ▲ 0.1 |
By gross margin, Medispar ranks 4th of 4 companies with main activity “Groothandel in farmaceutische producten” in Brussel that publish figures (fiscal year 2025).
Key figures of Medispar, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Medispar the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Medispar?
What happened at Medispar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.2 million. Source: NBB ↗
- Capital increase of € 1.4 million, published in the Gazette. Source: Staatsblad ↗
- Saesco Medical S.L. became a director. NBB
- Capital increase of € 3,772, published in the Gazette. Source: Staatsblad ↗
- Capital increase of € 20,820, published in the Gazette. Source: Staatsblad ↗
- Capital increase of € 3,800, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 534,261 profit in 2022 to € 1.2 million loss in 2025.
Paid € 632,414 in corporate taxes since 2022.
Best year ever: 2023, with € 1.5 million profit.
On average € 37,400 of value added per employee in 2025.
Management
Behind Medispar is Saesco Medical S.L.. It owns 100% of Healthcare Marketing Services S.O.O. and 100% of Pelvitec B.V. (NL) itself.
Directors
According to the 2025 annual accounts
Saesco Medical S.L.
Director · represented by Fluvià Carreras Jordi
since 2022
Establishments
Establishment units
Physical locations of this company
Koloniënstraat 11
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Groothandel in farmaceutische producten), 6 active companies in Brussel, largest first.
€ 294.3 million revenue · 2025
€ 71.3 million revenue · 2025
€ 18.7 million revenue · 2025
LABORATOIRES FORTE PHARMA BENELUX
€ 1.6 million gross margin · 2025
€ 425,255 gross margin · 2025
€ 288,670 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- SAESCO MEDICAL SL(inschrijver en inbrenger in natura (achtergestelde lening)) 89.5%
Capital increase
Source: Deed ↗- POMABI INVESTMENTS 2021, SL.(inschrijver) 2.3%
Capital increase
Source: Deed ↗- Diane Neirynck(vennoot Categorie C)
Incorporation
Source: Deed ↗- WILLEMS Jan Marie Ghislain(oprichter) 50%
- SEGERS Johan Jaak René(oprichter) 49.8%
- SEGMED(oprichter) 0.2%
Details
- Company number
- 0875.667.302
- VAT number
- BE 0875.667.302
- Registered office
- Koloniënstraat 11, 1000 Brussel
- Names & denominations
- Medispar
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 August 2005
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering